Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Participants receiving semaglutide demonstrated lower post-treatment drinking and craving scores, and while changes in overall drinking days were not observed, there was a progressive decline in heavy drinking days within the semaglutide group (Hendershot et al., 2025)
League tables presenting all pairwise comparisons with 95% CIs were produced
Unlike quick-acting supplements, L-Carnitine works gradually, showing the best results with consistent use over 512 weeks
At present, there is no NICE guidance, MHRA approval, or NHS commissioning pathway for the use of GLP-1 agonists in treating alcohol use disorder
McArdle BH, Anderson MJ (2001) Fitting multivariate models to community data: a comment on distance-based redundancy analysis
US$ 28.15
US$ 24.62
US$ 27.47
US$ 20.68
US$ 24.43
US$ 27.73
US$ 27.32
US$ 20.29
US$ 24.65
US$ 25.82
US$ 29.71
